Shaili Gupta

Summary

Publications

  1. pmc Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects
    Shaili Gupta
    Yale University School of Medicine, New Haven, CT 06510, USA
    Viruses 6:3428-37. 2014
  2. pmc Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications
    Shaili Gupta
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT 06510 2283, USA
    J Urban Health 86:263-79. 2009
  3. doi request reprint Raltegravir with unboosted atazanavir 300 mg twice daily in antiretroviral treatment-experienced participants
    Shaili Gupta
    Division of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:87-92. 2009
  4. doi request reprint Persistent and relapsing babesiosis in immunocompromised patients
    Peter J Krause
    Division of Infectious Diseases, Connecticut Children s Medical Center, and Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut 06106, USA
    Clin Infect Dis 46:370-6. 2008

Collaborators

  • Max Lataillade
  • Frederick L Altice
  • Gail Skowron
  • M J Kozal
  • Peter J Krause
  • Mary Young
  • Donald Heiman
  • Jennifer E Girotto
  • Ellen Neuhaus
  • David Hill
  • Diane Christianson
  • Sam R Telford
  • Benjamin E Gewurz
  • Barry Hartman
  • Andrew Spielman
  • John Dickason
  • Frank J Bia
  • Gary P Wormser
  • Jeffrey A Gelfand
  • Kenneth Dardick
  • Morton Coleman
  • Edouard Vannier
  • Richard R Furman
  • Carlo McCalla
  • Ivo M Foppa
  • Edward L Pesanti
  • Francisco M Marty
  • Gunther Hsue

Detail Information

Publications4

  1. pmc Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects
    Shaili Gupta
    Yale University School of Medicine, New Haven, CT 06510, USA
    Viruses 6:3428-37. 2014
    ..We recommend further evaluation of all low-frequency NNRTI-drug resistant variants with special attention given to the impact of mutational loads of these variants on treatment outcomes. ..
  2. pmc Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications
    Shaili Gupta
    Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT 06510 2283, USA
    J Urban Health 86:263-79. 2009
    ..We present a review of diagnosis, prevention, and the recently streamlined treatment guidelines for management of HBV infection in correctional settings, and discuss the implications and public health impact of these measures...
  3. doi request reprint Raltegravir with unboosted atazanavir 300 mg twice daily in antiretroviral treatment-experienced participants
    Shaili Gupta
    Division of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:87-92. 2009
    ..All patients tolerated this regimen over a course of 25 to 82 weeks, and had good virologic and immunologic outcome with a decrease in HIV RNA levels to <50 copies/mL and a mean CD4 count increase of 234 cells/mm(3)...
  4. doi request reprint Persistent and relapsing babesiosis in immunocompromised patients
    Peter J Krause
    Division of Infectious Diseases, Connecticut Children s Medical Center, and Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut 06106, USA
    Clin Infect Dis 46:370-6. 2008
    ..Although patients experiencing babesiosis that is unresponsive to standard antimicrobial therapy have been described, the pathogenesis, clinical course, and optimal treatment regimen of such cases remain uncertain...